Development of manufacturing lymphocytes for clinical use in a cell proccessing facility

Development of manufacturing lymphocytes for clinical use in a cell proccessing facility - Development of manufacturing lymphocytes for clinical use

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013947

Enrollment

Registered

2014-05-13

Start date

2014-05-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

Apheresis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: # aged from 20 to 55 years # easy access to an upper limb vein # no blood donation or intervation within a month # healthy volunteer assessed by Takara Bio Inc.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
cell culture, gene transduction and safety	—

Countries

Japan

Contacts

Public ContactShinichi Kageyama

Mie University Graduate School of Medicine Immuno-Gene Therapy

kageyama@clin.medic.mie-u.ac.jp059-231-5187

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026